Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on February 3, 2015, to announce its fourth quarter and full-year 2014 financial results. The report primarily directs investors to an accompanying press release (Exhibit 99.1) for detailed financial information, presented under both U.S. GAAP and non-GAAP measures. Management believes the non-GAAP presentation offers valuable insights for investors as it is used internally for operational and financial planning. While the 8-K itself does not contain the specific financial figures, it signals the release of key performance data. Investors should consult the referenced press release for comprehensive details on revenue, profitability, and other financial metrics for the periods ending December 31, 2014, and December 31, 2013. The company emphasizes that non-GAAP information should be considered supplementary to its official GAAP financial statements.
Key Highlights
- 1Gilead Sciences announced its Q4 and full-year 2014 financial results on February 3, 2015.
- 2The primary disclosure mechanism is a press release (Exhibit 99.1), not the 8-K itself.
- 3Financial results are presented on both U.S. GAAP and non-GAAP bases.
- 4Management considers non-GAAP results useful for investors and internal planning.
- 5A reconciliation between GAAP and non-GAAP figures is available in the press release.
- 6The filing is for informational purposes and information is not deemed 'filed' for certain securities law purposes.